PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-11.95%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$1.09B
AUM Growth
+$1.09B
(-29%)
Cap. Flow
-$113M
Cap. Flow
% of AUM
-10.35%
Top 10 Holdings %
Top 10 Hldgs %
56.79%
Holding
201
New
29
Increased
30
Reduced
41
Closed
48
Top Buys
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$38.9M |
| 2 |
Regenxbio
RGNX
|
$17.2M |
| 3 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$11.5M |
| 4 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$11.2M |
| 5 |
DBVT
DBV Technologies
DBVT
|
$10.8M |
Top Sells
| 1 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
$19M |
| 2 |
AGN
Allergan plc
AGN
|
$18M |
| 3 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
$17M |
| 4 |
RDUS
Radius Health, Inc.
RDUS
|
$15.9M |
| 5 |
Zimmer Biomet
ZBH
|
$14.8M |
Sector Composition
| 1 | Healthcare | 89.15% |
| 2 | Consumer Discretionary | 0.07% |
| 3 | Financials | 0.04% |
| 4 | Energy | 0.02% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $176M | 14.03% | 14,439,444 | – | – |
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $117M | 9.35% | 2,942,967 -341,500 | -10% | -$13.6M |
|
3
Sarepta Therapeutics
SRPT
$1.78B
| $89.4M | 7.14% | 2,784,928 -24,600 | -0.9% | -$790K |
|
4
Travere Therapeutics
TVTX
$1.56B
| $53.6M | 4.28% | 2,647,080 -173,795 | -6% | -$3.52M |
|
|
TSRO
5
DELISTED
TESARO, Inc.
TSRO
| $39.4M | 3.14% | 981,759 +146,400 | +18% | +$5.87M |
|
|
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $38.9M | 3.1% | +921,800 | New | +$38.9M |
|
|
DYAX
7
DELISTED
DYAX CORPORATION
DYAX
| $31.4M | 2.51% | 1,646,315 -140,000 | -8% | -$2.67M |
|
|
NVRO
8
DELISTED
NEVRO CORP.
NVRO
| $28.2M | 2.25% | 606,811 -192,148 | -24% | -$8.91M |
|
|
ARAV
9
DELISTED
Aravive, Inc. Common Stock
ARAV
| $26.7M | 2.13% | 2,317,954 +996,554 | +75% | +$11.5M |
|
10
Xencor
XNCR
$580M
| $21.5M | 1.71% | 1,754,784 -130,000 | -7% | -$1.59M |
|
11
Talphera
TLPH
$11.1M
| $19.1M | 1.53% | 6,264,060 -310,000 | -5% | -$945K |
|
|
RLYP
12
DELISTED
RELYPSA INC COM
RLYP
| $18.3M | 1.46% | 987,942 -151,200 | -13% | -$2.8M |
|
|
LJPC
13
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $18.2M | 1.45% | 654,515 +401,600 | +159% | +$11.2M |
|
|
14
Regenxbio
RGNX
$451M
| $17.2M | 1.37% | +779,213 | New | +$17.2M |
|
15
Iovance Biotherapeutics
IOVA
$807M
| $17M | 1.36% | 2,955,456 +195,863 | +7% | +$1.13M |
|
|
RXDX
16
DELISTED
Ignyta, Inc.
RXDX
| $17M | 1.35% | 1,931,600 -36,000 | -2% | -$316K |
|
|
CEMP
17
DELISTED
Cempra, Inc.
CEMP
| $16.2M | 1.3% | 582,500 +10,000 | +2% | +$278K |
|
|
PFNX
18
DELISTED
Pfenex Inc.
PFNX
| $14.6M | 1.16% | 971,043 -39,834 | -4% | -$598K |
|
19
uniQure
QURE
$896M
| $14.1M | 1.13% | 690,269 +40,000 | +6% | +$818K |
|
20
Sonida Senior Living
SNDA
$488M
| $11.1M | 0.89% | 553,600 -86,900 | -14% | -$1.74M |
|
|
DERM
21
DELISTED
Dermira, Inc.
DERM
| $11M | 0.88% | 472,000 +320,000 | +211% | +$7.47M |
|
|
DBVT
22
DBV Technologies
DBVT
$264M
| $10.9M | 0.87% | 306,715 +303,713 | +10,117% | +$10.8M |
|
|
QTNT
23
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $10.3M | 0.83% | 776,803 +214,367 | +38% | +$2.86M |
|
24
Acadia Pharmaceuticals
ACAD
$4.38B
| $9.76M | 0.78% | 295,240 -115,000 | -28% | -$3.8M |
|
25
Cidara Therapeutics
CDTX
$1.66B
| $9.45M | 0.75% | 742,858 +442,858 | +148% | +$5.63M |
|